FDA Generic Drug Facility Self-Identification for FY 2014 to Run May 1 - June 1
The Food and Drug Administration will begin its month-long reporting period for generic drug facility self-identification for fiscal year 2014 on May 1. Between May 1 and June 1, generic drug facilities, certain sites, and organizations identified in a generic…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
drug submission are required to submit, update, or reconfirm identification information to FDA, it said. More information, including generic drug facilities that have to register, is available (here).